Ubiquitin ligase Cbl-b and obesity-induced insulin resistance

Endocrine Journal

Volumn 61, Issue 6, 2014, Pages 529-538

  Abe, Tomoki ^a   Hirasaka, Katsuya ^a   Kohno, Shohei ^b   Ochi, Arisa ^a   Yamagishi, Naoko ^a   Ohno, Ayako ^a   Teshima Kondo, Shigetada ^a   Nikawa, Takeshi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Cbl b; Insulin resistance; Macrophage; Obesity; TLR4

Indexed keywords

CBL B PROTEIN; CBL PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VAV PROTEIN; CBLB PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADIPOCYTE; AGING; CELL EXPANSION; CELL INFILTRATION; CELL MEMBRANE DEPOLARIZATION; CYTOKINE PRODUCTION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; M1 MACROPHAGE; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MONOCYTE; NONHUMAN; OBESITY; PATHOGENESIS; PROTEIN DEFICIENCY; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; COMPLICATION; ENZYMOLOGY; GENETICS; HUMAN; IMMUNE SYSTEM; METABOLISM; MOUSE; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGING; ANIMALS; DIET, HIGH-FAT; HUMANS; IMMUNE SYSTEM; INSULIN RESISTANCE; MACROPHAGE ACTIVATION; MICE; OBESITY; PROTO-ONCOGENE PROTEINS C-CBL;

EID: 84903633510     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ14-0048     Document Type: Review

References (77)

1. Wellen KE, Thompson CB (2010) Cellular metabolic stress: considering how cells respond to nutrient excess. Mol Cell 40: 323-332.
2. Barzilai N, Huffman DM, Muzumdar RH, Bartke A (2012) The critical role of metabolic pathways in aging. Diabetes 61: 1315-1322.
3. Shoelson SE (2006) Banking on ATM as a new target in metabolic syndrome. Cell Metab 4: 337-338.
4. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nat Med. 444: 860-867.
5. González-Rodríguez A, Más-Gutierrez JA, Mirasierra M, Fernandez-Pérez A, Lee YJ, et al. (2012) Essential role of protein tyrosine phosphatase 1B in obesity-induced inflammation and peripheral insulin resistance during aging. Aging Cell 11: 284-296.
6. Osborn O, Olefsky JM (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 18: 363-374.
7. Yin MJ, Yamamoto Y, Gaynor RB (1998) The anti-in-flammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396: 77-80.
8. Shoelson SE, Lee J, Yuan M (2003) Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord Suppl 3: S49-S52.
9. McGee KC, Harte AL, da Silva NF, Al-Daghri N, Creely SJ (2011) Visfatin is regulated by rosiglitazone in type 2 diabetes mellitus and influenced by NFκB and JNK in human abdominal subcutaneous adipocytes. PLoS One 6: e20287.
10. Lumeng CN, Saltiel AR (2011) Inflammatory links between obesity and metabolic disease. J Clin Invest 121: 2111-2117.
11. Pickart CM (2001) Mechanisms underlying ubiquitina-tion. Annu Rev Biochem 70: 503-533.
12. Thien CB, Langdon WY (2001) Cbl: many adaptations to regulate protein tyrosine kinases. Nat Rev Mol Cell Biol 2: 294-307.
13. Meng W, Sawasdikosol S, Burakoff SJ, Eck MJ (1999) Structure of the amino-terminal domain of Cbl com-plexed to its binding site on ZAP-70 kinase. Nature 398: 84-90.
14. Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, et al. (1999) Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol Cell 4: 1029-1040.
15. Fang D, Liu YC (2001) Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nat Immunol 2: 870-875.
16. Ettenberg SA, Keane MM, Nau MM, Frankel M, Wang LM, et al. (1999) CBL-b inhibits epidermal growth factor receptor signaling. Oncogene 18: 1855-1866.
17. Naramura M, Jang IK, Kole H, Huang F, Haines D, et al. (2002) C-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation. Nat Immunol 3: 1192-1199.
18. Sohn HW, Gu H, Pierce SK (2003) Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk. J Exp Med 197: 1511-1524.
19. Suzue N, Nikawa T, Onishi Y, Yamada C, Hirasaka K, et al. (2006) Ubiquitin ligase Cbl-b downregulates bone formation through suppression of IGF-I signaling in osteoblasts during denervation. J Bone Miner Res 21: 722-734.
20. Yokoi N, Fujiwara Y, Wang HY, Kitao M, Hayashi C, et al. (2008) Identifcation and functional analysis of CBLB mutations in type 1 diabetes. Biochem Biophys Res Commun 368: 37-42.
21. Sanna S, Pitzalis M, Zoledziewska M, Zara I, Sidore C, et al. (2010) Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. Nat Genet 42: 495-497.
22. Bachmaier K, Krawczyk C, Kozieradzki I, Kong YY, Sasaki T, et al. (2000) Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403: 211-216.
23. Chiang YJ, Kole HK, Brown K, Naramura M, Fukuhara S, et al. (2000) Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403: 216-220.
24. Schwartz RH (2003) T cell anergy. Annu Rev Immunol 21: 305-334.
25. Heissmeyer V, Macián F, Im SH, Varma R, Feske S, et al. (2004) Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat Immunol 5: 255-265.
26. Gruber T, Hermann-Kleiter N, Hinterleitner R, Fresser F, Schneider R, et al. (2009) PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiq-uitination and degradation. Sci Signal 2: ra30.
27. Keane MM, Rivero-Lezcano OM, Mitchell JA, Robbins KC, Lipkowitz S (1995) Cloning and characterization of cbl-b: a SH3 binding protein with homology to the c-cbl proto-oncogene. Oncogene 10: 2367-2377.
28. Choi E Y, Orlova VV, Fagerholm SC, Nurmi SM, Zhang L, et al. (2008) Regulation of LFA-1-dependent inflam-matory cell recruitment by Cbl-b and 14-3-3 proteins. Blood 111: 3607-3614.
29. Han C, Jin J, Xu S, Liu H, Li N, et al. (2010) Integrin CD11b negatively regulates TLR-triggered inflamma-tory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat Immunol 11: 734-742.
30. Nakajima A, Sanjay A, Chiusaroli R, Adapala NS, Neff L, et al. (2009) Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia. J Bone Miner Res 24: 1162-1172.
31. Muzumdar R, Ma X, Atzmon G, Vuguin P, Yang X, et al. (2004) Decrease in glucose-stimulated insulin secretion with aging is independent of insulin action. Diabetes 53: 441-446.
32. Bloch-Damti A, Bashan N (2005) Proposed mechanisms for the induction of insulin resistance by oxida-tive stress. Antioxid Redox Signal 7: 1553-1567.
33. Yang Z, Ming XF (2012) MTOR signaling: the molecular interface connecting metabolic stress, aging and cardiovascular diseases. Obes Rev 13 Suppl 2: 58-68.
34. Carrascosa JM, Andrés A, Ros M, Bogónez E, Arribas C, et al. (2011) Development of insulin resistance during aging: involvement of central processes and role of adipokines. Curr Protein Pept Sci 12: 305-315.
35. Suganami T, Tanaka M, Ogawa Y (2012) Adipose tissue inflammation and ectopic lipid accumulation. Endocr J 59: 849-857.
36. Ota T (2013) Chemokine systems link obesity to insulin resistance. Diabetes Metab J 37: 165-172.
37. Proudfoot AE (2002) Chemokine receptors: multifac-eted therapeutic targets. Nat Rev Immunol 2: 106-115.
38. Oh DY, Morinaga H, Talukdar S, Bae EJ, Olefsky JM (2012) Increased macrophage migration into adipose tissue in obese mice. Diabetes 61: 346-354.
39. Hirasaka K, Kohno S, Goto J, Furochi H, Mawatari K, et al. (2007) Deficiency of Cbl-b gene enhances infiltra-tion and activation of macrophages in adipose tissue and causes peripheral insulin resistance in mice. Diabetes 56: 2511-2522.
40. Yokoi N, Hayashi C, Fujiwara Y, Wang HY, Seino S (2007) Genetic reconstitution of autoimmune type 1 diabetes with two major susceptibility genes in the rat. Diabetes 56: 506-512.
41. Wells CM, Bhavsar PJ, Evans IR, Vigorito E, Turner M, et al. (2005) Vav1 and Vav2 play different roles in mac-rophage migration and cytoskeletal organization. Exp Cell Res 310: 303-310.
42. Tong H, Zhao B, Shi H, Ba X, Wang X, et al. (2013) C-Abl tyrosine kinase plays a critical role in β2 integ-rin-dependent neutrophil migration by regulating Vav1 activity. J Leukoc Biol 93: 611-622.
43. Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue mac-rophage polarization. J Clin Invest 117: 175-184.
44. Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830.
45. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with mac-rophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
46. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, et al. (2008) Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8: 301-309.
47. Olefsky JM, Glass CK (2010) Macrophages, inflamma-tion, and insulin resistance. Annu Rev Physiol 72: 219-246.
48. Liao X, Sharma N, Kapadia F, Zhou G, Lu Y, et al. (2011) Krüppel-like factor 4 regulates macrophage polarization. J Clin Invest 121: 2736-2749.
49. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, et al. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116: 3015-3025.
50. Suganami T, Tanimoto-Koyama K, Nishida J, Itoh M, Yuan X, et al. (2007) Role of the Toll-like receptor 4/ NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipo-cytes and macrophages. Arterioscler Thromb Vasc Biol 27:84-91.
51. Yamamoto M, Akira S (2009) Lipid A receptor TLR4-mediated signaling pathways. Adv Exp Med Biol 667: 59-68.
52. Kim JI, Lee CJ, Jin MS, Lee CH, Paik SG, et al. (2005) Crystal structure of CD14 and its implications for lipopolysaccharide signaling. J Biol Chem 280: 11347-11351.
53. Schaeffer A, Gross P, Buettner R, Bollheimer C, Buechler C, et al. (2009) Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology 126: 233-245.
54. Erridge C, Samani NJ (2009) Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arterioscler Thromb Vasc Biol 29: 1944-1949.
55. Pal D, Dasgupta S, Kundu R, Maitra S, Das G, et al. (2012) Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 18: 1279-1285.
56. Abe T, Hirasaka K, Kagawa S, Kohno S, Ochi A, et al. (2013) Cbl-b is a critical regulator of macrophage activation associated with obesity-induced insulin resistance in mice. Diabetes 62: 1957-1969.
57. Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Koniaris LG, et al. (2003) Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-depen-dent insulin resistance in hepatocytes. J Biol Chem 278: 13740-13746.
58. Medvedev AE, Piao W, Shoenfelt J, Rhee SH, Chen H, et al. (2007) Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance. J Biol Chem 282: 16042-16053.
59. Bachmaier K, Toya S, Gao X, Triantafllou T, Garrean S, et al. (2007) E3 ubiquitin ligase Cblb regulates the acute inflammatory response underlying lung injury. Nat Med 13: 920-926.
60. Saberi M, Woods NB, de Luca C, Schenk S, Lu JC, et al. (2009) Hematopoietic cell-specific deletion of tolllike receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab 10: 419-429.
61. Herrero L, Shapiro H, Nayer A, Lee J, Shoelson SE (2010) Inflammation and adipose tissue macrophages in lipodystrophic mice. Proc Natl Acad Sci U S A 107: 240-245.
62. Huang-Doran I, Sleigh A, Rochford JJ, O'Rahilly S, Savage DB (2010) Lipodystrophy: metabolic insights from a rare disorder. J Endocrinol 207: 245-255.
63. Kim HM, Park BS, Kim JI, Kim SE, Lee J, et al. (2007) Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130: 906-917.
64. Molero JC, Jensen TE, Withers PC, Couzens M, Herzog H, et al. (2004) C-Cbl-defcient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action. J Clin Invest 114: 1326-1333.
65. Molero JC, Waring SG, Cooper A, Turner N, Laybutt R, et al. (2006) Casitas b-lineage lymphoma-deficient mice are protected against high-fat diet-induced obesity and insulin resistance. Diabetes 55: 708-715.
66. Molero JC, Turner N, Thien CB, Langdon WY, James DE, et al. (2006) Genetic ablation of the c-Cbl ubiquitin ligase domain results in increased energy expenditure and improved insulin action. Diabetes 55: 3411-3417.
67. Yokouchi M, Wakioka T, Sakamoto H, Yasukawa H, Ohtsuka S, et al. (1999) APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis. Oncogene 18: 759-767.
68. Boussiotis VA, Freeman GJ, Berezovskaya A, Barber DL, Nadler LM (1997) Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science 278: 124-128.
69. Zhang W, Shao Y, Fang D, Huang J, Jeon MS, et al. (2003) Negative regulation of T cell antigen receptor-mediated Crk-L-C3G signaling and cell adhesion by Cbl-b. J Biol Chem 278: 23978-23983.
70. Nakao R, Hirasaka K, Goto J, Ishidoh K, Yamada C, et al. (2009) Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading. Mol Cell Biol 29: 4798-4811.
71. Miyake S, Mullane-Robinson KP, Lill NL, Douillard P, Band H (1999) Cbl-mediated negative regulation of platelet-derived growth factor receptor-dependent cell proliferation. A critical role for Cbl tyrosine kinase-binding domain. J Biol Chem 274: 16619-16628.
72. Hunter S, Burton EA, Wu SC, Anderson SM (1999) Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase. J Biol Chem 274: 2097-2106.
73. Fong CW, Leong HF, Wong ES, Lim J, Yusoff P, et al. (2003) Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function. J Biol Chem 278: 33456-33464.
74. Sanjay A, Houghton A, Neff L, DiDomenico E, Bardelay C, et al. (2001) Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-medi-ated signaling, cell adhesion, and osteoclast motility. J Cell Biol 152: 181-195.
75. Duan L, Raja SM, Chen G, Virmani S, Williams SH, et al. (2011) Negative regulation of EGFR-Vav2 signaling axis by Cbl ubiquitin ligase controls EGF receptor-mediated epithelial cell adherens junction dynamics and cell migration. J Biol Chem 286: 620-633.
76. Rao N, Dodge I, Band H (2002) The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system. J Leukoc Biol 71: 753-763.
77. Zhang Z, Elly C, Qiu L, Altman A, Liu YC (1999) A direct interaction between the adaptor protein Cbl-b and the kinase zap-70 induces a positive signal in T cells. Curr Biol 9: 203-206.